By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Corbus Pharmaceuticals, Inc.  

100 River Ridge Drive

Norwood  Massachusetts  02062   U.S.A.
Phone: 1-617-963-0100 Fax: 1-617-663-6085


Company News
Corbus To Present At The JMP Securities Life Sciences Conference On June 23, 2015 6/18/2015 12:31:36 PM
Corbus Announces Inclusion In Russell MicroCap Index 6/16/2015 11:13:14 AM
Corbus Announces FDA Orphan Drug Designation For Resunab For The Treatment Of Systemic Sclerosis (Scleroderma) 6/12/2015 11:11:32 AM
Corbus Expands Clinical Development Of Resunab With A Phase 2 Trial For The Treatment Of Rare Disease Dermatomyositis 6/8/2015 10:46:23 AM
Corbus Announces Presentation Of Positive Data On Resunab In Pre-Clinical Models Of Cystic Fibrosis At The 2015 Cystic Fibrosis Foundation Research Conference 6/2/2015 1:21:29 PM
Day in the Life of a CEO—Yuval Cohen, Corbus 5/28/2015 10:23:10 AM
Corbus Receives FDA Clearance To Initiate Phase 2 Clinical Study of Resunab For The Treatment Of Cystic Fibrosis 5/18/2015 12:07:37 PM
Corbus Will Interview Twice as Many Candidates in 2015 as Its Ranks Grow 5/18/2015 12:05:26 PM
Corbus Reports 2015 First Quarter Financial Results And Provides Business Update 5/14/2015 11:02:55 AM
Corbus Appoints Charles N. Serhan, Ph.D., To Scientific Advisory Board 5/14/2015 11:00:50 AM